The manufacturer of a breast cancer drug which has been deemed "too expensive" to be offered by the NHS has hit back at the decision.
Dr Jayson Dallas, general manager of Roche Products Limited, declared it "an incredible injustice."
Despite Roche offering a significant discount, we are once again disappointed that Nice has not shown any flexibility on access to Kadcyla.
Refusing patients access to this drug is an incredible injustice and tantamount to turning the clock back in cancer research and development. We plan to appeal this decision.
More top news
Colonel Richard Kemp told ITV News Britain must send in ground troops to have any chance of stopping the terror group.
Severe gales will gradually ease across the country but a wet night in the south of England and Wales and icy stretches in Scotland.
Two fathers' rights activists have avoided police and managed to climb on the roof of a public art gallery at Buckingham Palace.